KF
Kopp Funds Portfolio holdings
AUM
$221M
1 Year Est. Return
–
AUM
$221M
AUM Growth
–
Holding
64
Top Buys
| 1 | +$24.8M | |
| 2 | +$24.3M | |
| 3 | +$15.3M | |
| 4 |
ALU
Alcatel-Lucent
ALU
|
+$14.1M |
| 5 |
VTSS
VITESSE SEMICONDUCTOR CORPORATION COMMON STOCK
VTSS
|
+$12.6M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 46.62% |
| 2 | Healthcare | 22.58% |
| 3 | Consumer Staples | 4.04% |
| 4 | Financials | 1.92% |
| 5 | Industrials | 1.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Southern Company
SO
$101B
| $832K | 0.38% |
+20,242
|
|
||
52
IBM
IBM
$286B
| $823K | 0.37% |
+4,589
|
|
||
53
PepsiCo
PEP
$195B
| $794K | 0.36% |
+9,576
|
|
||
54
Procter & Gamble
PG
$343B
| $765K | 0.35% |
+9,396
|
|
||
55
NeoGenomics
NEO
$1.3B
| $550K | 0.25% |
+152,057
|
|
||
56
Vanguard Total Stock Market ETF
VTI
$547B
| $374K | 0.17% |
+3,900
|
|
||
57
Vanguard Short-Term Corporate Bond ETF
VCSH
$39.3B
| $239K | 0.11% |
+3,000
|
|
||
58
Invesco QQQ Trust
QQQ
$387B
| $237K | 0.11% |
+2,700
|
|
||
59
Ligand Pharmaceuticals
LGND
$3.95B
| $211K | 0.1% |
+6,418
|
|
||
|
ACCL
60
DELISTED
Accelrys Inc
ACCL
| $184K | 0.08% |
+19,310
|
|
||
61
Cytokinetics
CYTK
$7.36B
| $176K | 0.08% |
+27,001
|
|
||
|
PMCS
62
DELISTED
P M C SIERRA INC
PMCS
| $129K | 0.06% |
+20,000
|
|
||
|
NXTM
63
DELISTED
NxStage Medical Inc.
NXTM
| $110K | 0.05% |
+11,020
|
|
||
64
LeMaitre Vascular
LMAT
$1.97B
| $107K | 0.05% |
+13,415
|
|